Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Roux-Lombard

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|March 1, 1997
Levels of cytokine inhibitors: a possible marker of disease activity in childhood dermatomyositis and polymyositisA M Prieur, A Dayer, P Roux-Lombard, et al.
British Journal of Rheumatology|February 4, 1998
Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosusG Sturfelt, P Roux-Lombard, F A Wollheim, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
The Journal of Rheumatology|April 1, 1992
Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cellsP Roux-Lombard, C Modoux, T Vischer, et al.
Revue Medicale Suisse|May 18, 2010
[External quality controls for allergy analysis in the Quality Control Center Switzerland from 2006 to 2008]E Dayer, D Kesseler, P-A Morandi, et al.
British Journal of Rheumatology|May 1, 1994
Elevated serum levels of TNF soluble receptors in patients with positive anti-neutrophil cytoplasmic antibodiesP Roux-Lombard, H C Lin, J B Peter, et al.
The Journal of Clinical Investigation|January 1, 1990
Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cellsC Ucla, P Roux-Lombard, S Fey, et al.
Clinical and Experimental Immunology|April 1, 1993
Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritisI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Clinical and Experimental Rheumatology|January 4, 2001
Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitisS Hurst, C Chizzolini, J M Dayer, et al.
Rheumatology (Oxford, England)|May 24, 2001
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year studyP Roux-Lombard, K Eberhardt, T Saxne, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|March 1, 1997
Levels of cytokine inhibitors: a possible marker of disease activity in childhood dermatomyositis and polymyositisA M Prieur, A Dayer, P Roux-Lombard, et al.
British Journal of Rheumatology|February 4, 1998
Low levels of interleukin-1 receptor antagonist coincide with kidney involvement in systemic lupus erythematosusG Sturfelt, P Roux-Lombard, F A Wollheim, et al.
Arthritis and Rheumatism|May 1, 1995
Dysregulation of the in vivo production of interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Pathogenetic implicationsI C Chikanza, P Roux-Lombard, J M Dayer, et al.
The Journal of Rheumatology|April 1, 1992
Inhibitors of interleukin 1 activity in synovial fluids and in cultured synovial fluid mononuclear cellsP Roux-Lombard, C Modoux, T Vischer, et al.
Revue Medicale Suisse|May 18, 2010
[External quality controls for allergy analysis in the Quality Control Center Switzerland from 2006 to 2008]E Dayer, D Kesseler, P-A Morandi, et al.
British Journal of Rheumatology|May 1, 1994
Elevated serum levels of TNF soluble receptors in patients with positive anti-neutrophil cytoplasmic antibodiesP Roux-Lombard, H C Lin, J B Peter, et al.
The Journal of Clinical Investigation|January 1, 1990
Interferon gamma drastically modifies the regulation of interleukin 1 genes by endotoxin in U937 cellsC Ucla, P Roux-Lombard, S Fey, et al.
Clinical and Experimental Immunology|April 1, 1993
Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritisI C Chikanza, P Roux-Lombard, J M Dayer, et al.
Clinical and Experimental Rheumatology|January 4, 2001
Usefulness of serum eosinophil cationic protein (ECP) in predicting relapse of Churg and Strauss vasculitisS Hurst, C Chizzolini, J M Dayer, et al.
Rheumatology (Oxford, England)|May 24, 2001
Cytokines, metalloproteinases, their inhibitors and cartilage oligomeric matrix protein: relationship to radiological progression and inflammation in early rheumatoid arthritis. A prospective 5-year studyP Roux-Lombard, K Eberhardt, T Saxne, et al.
Pageof 7